Cel-Sci
CVM
#9869
Rank
A$61.48 M
Marketcap
A$7.31
Share price
-5.19%
Change (1 day)
-60.59%
Change (1 year)

Cel-Sci (CVM) - P/B ratio

P/B ratio as of February 2026 : 2.85

According to Cel-Sci 's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Cel-Sci - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-315.8873.56%
2024-12-313.39-68.49%
2023-12-3110.7178.4%
2022-12-313.86-35.44%
2021-12-315.98-62.81%
2020-12-3116.1-65.99%
2019-12-3147.360.16%
2018-12-3129.5-671.6%
2017-12-31-5.16-280.47%
2016-12-312.86-79.02%
2015-12-3113.6203.68%
2014-12-314.49105.24%
2013-12-312.19-69.52%
2012-12-317.18-12.64%
2011-12-318.2211.11%
2010-12-317.3935.89%
2009-12-315.4457.29%
2008-12-313.46-17.36%
2007-12-314.19-116.23%
2006-12-31-25.8-289.3%
2005-12-3113.630.28%
2004-12-3110.5-52.21%
2003-12-3121.9102.53%
2002-12-3110.8

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
7.01 146.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
19.3 578.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
1.38-51.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-0.7674-126.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
5.62 97.42%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
-4.24-248.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
1.07-62.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
2.73-4.19%๐Ÿ‡บ๐Ÿ‡ธ USA